Zachary P. Holmes

Fitzroy, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Terbinafine-Resistant Trichophyton Dermatophytosis in Australia.

Terbinafine-Resistant Trichophyton Dermatophytosis in Australia.

Journal: The Australasian journal of dermatology
Published: November 12, 2025

Mpox With Multiple Atypical Presentations: A Case Report.

Mpox With Multiple Atypical Presentations: A Case Report.

Journal: The Australasian journal of dermatology
Published: September 19, 2025

A case of Morbihan syndrome successfully treated with high dose omalizumab.

A case of Morbihan syndrome successfully treated with high dose omalizumab.

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: June 25, 2025

Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies.

Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies.

Journal: The Australasian journal of dermatology
Published: April 12, 2025

Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant Disease.

Upadacitinib for Chronic Actinic Dermatitis: A Case Report and Literature Review of JAK Inhibitor Use for Recalcitrant Disease.

Journal: The Australasian journal of dermatology
Published: November 18, 2024

Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review.

Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review.

Journal: The Australasian journal of dermatology
Published: October 15, 2024

Dupilumab for chronic actinic dermatitis: A case series and review of the literature.

Dupilumab for chronic actinic dermatitis: A case series and review of the literature.

Journal: The Australasian journal of dermatology
Published: February 27, 2024

Tildrakizumab use for recalcitrant pityriasis rubra pilaris.

Tildrakizumab use for recalcitrant pityriasis rubra pilaris.

Journal: The Australasian journal of dermatology
Published: January 22, 2024

Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisation.

Non-cirrhotic hyperammonaemic encephalopathy secondary to metastatic pancreatic neuroendocrine tumour treated with peptide receptor radio nucleotide therapy and transarterial chemoembolisation.

Journal: BMJ case reports
Published: January 03, 2024

Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin.

Treatment of severe, refractory pyoderma gangrenosum with infliximab, adalimumab and intravenous immunoglobulin.

Journal: The Australasian journal of dermatology
Published: January 17, 2023

Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum.

Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum.

Journal: The Australasian journal of dermatology
Published: September 28, 2022

Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy.

Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy.

Journal: BMJ case reports
Published: August 10, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026